ISIN | CH0517863152 |
---|---|
Valor Number | 51786315 |
Bloomberg Global ID | |
Fund Name | Swisscanto (CH) Index Equity Fund United Kingdom MT GBP |
Fund Provider |
Swisscanto Fondsleitung AG
Zurich E-Mail: fonds@swisscanto.ch |
Fund Provider | Swisscanto Fondsleitung AG |
Representative in Switzerland | |
Distributor(s) | Schweizerische Kantonalbanken |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | The fund charges a transaction fee (contribution towards covering expenses incurred in the sale of assets) |
Investment Strategy *** | Die Anlagen dieses Teilvermögens erfolgen in Anlehnung an den MSCI® United Kingdom Index, welcher von der MORGAN STANLEY CAPITAL INTERNATIONAL INC. (MSCI) fest-gelegt und berechnet wird und darauf ausgelegt ist, die Performance der Mid- und Large Cap Segmente des Marktes des Vereinigten Königreiches (Grossbritannien und Nordirland) zu messen. |
Peculiarities |
Current Price * | 145.50 GBP | 16.09.2025 |
---|---|---|
Previous Price * | 146.79 GBP | 15.09.2025 |
52 Week High * | 147.43 GBP | 22.08.2025 |
52 Week Low * | 119.74 GBP | 09.04.2025 |
NAV * | 145.50 GBP | 16.09.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 150,715,934 | |
Unit/Share Assets *** | 9,198,423 | |
Trading Information SIX |
YTD Performance | +15.63% |
31.12.2024 - 16.09.2025
31.12.2024 16.09.2025 |
---|---|---|
YTD Performance (in CHF) | +9.29% |
31.12.2024 - 16.09.2025
31.12.2024 16.09.2025 |
1 month | +0.55% |
18.08.2025 - 16.09.2025
18.08.2025 16.09.2025 |
3 months | +4.71% |
16.06.2025 - 16.09.2025
16.06.2025 16.09.2025 |
6 months | +7.68% |
17.03.2025 - 16.09.2025
17.03.2025 16.09.2025 |
1 year | +14.87% |
16.09.2024 - 16.09.2025
16.09.2024 16.09.2025 |
2 years | +29.09% |
18.09.2023 - 16.09.2025
18.09.2023 16.09.2025 |
3 years | +41.18% |
16.09.2022 - 16.09.2025
16.09.2022 16.09.2025 |
5 years | +86.13% |
16.09.2020 - 16.09.2025
16.09.2020 16.09.2025 |
Equity Participation Rate in % | 98.01 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
AstraZeneca PLC | 8.56% | |
---|---|---|
HSBC Holdings PLC | 7.74% | |
Shell PLC | 7.52% | |
Unilever PLC | 5.34% | |
Rolls-Royce Holdings PLC | 4.22% | |
British American Tobacco PLC | 4.09% | |
BP PLC | 3.22% | |
RELX PLC | 2.96% | |
GSK PLC | 2.78% | |
BAE Systems PLC | 2.46% | |
Last data update | 31.08.2025 |
TER | 0.00% |
---|---|
TER date | 30.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | |
Ongoing Charges *** | 0.00% |
SRRI ***
|
|
SRRI date *** | 31.08.2025 |